TICKERNOMICS Sign up
Last Update: 2023-12-23 06:00:36
MESA LABORATORIES INC /CO/ ( MLAB ) https://www.mesalabs.com
104.33USD
Sector:
Technology
Industry:
Scientific & Technical Instruments
Country:
United States
1y
3y
5y
10y
Historical Returns*:
SPY
23.45%
-35.53%
MLAB
SPY
30.72%
-62.90%
MLAB
SPY
112.82%
-44.62%
MLAB
SPY
201.04%
MLAB
42.77%
*Assumes dividends reinvested
Market Stats:
Market Capitalization($MM)
Enterprise Value($MM)
Daily Volume(MM)
562.03
702.71
0.04
Valuation Metrics:
Price/Earnings Ratio
Price/Sales Ratio
Price/Book Value
FCF Yield(%)
Dividend Yield(%)
EV/EBITDA
-783.86
2.63
1.45
6.34
0.61
25.39
Profitability Stats:
Operating Margin %(ttm)
Gross Profit %(ttm)
EBITDA Margin %(ttm)
-0.11
60.39
12.95
Shareholder Value Creation:
Cost of Capital %(est)
ROIC %(ttm)
ROCE %(ttm)
Beta
7.9172
-1.34
-1.44
0.98
Other Earnings and Cash Flow Stats:
MESA LABORATORIES INC /CO/ ( MLAB ) Net Income TTM ($MM) is 1.14
MESA LABORATORIES INC /CO/ ( MLAB ) Operating Income TTM ($MM) is -1.20
MESA LABORATORIES INC /CO/ ( MLAB ) Owners' Earnings Annual ($MM) is 0.00
MESA LABORATORIES INC /CO/ ( MLAB ) Current Price to Owners' Earnings ratio is 0.00
MESA LABORATORIES INC /CO/ ( MLAB ) EBITDA TTM ($MM) is 32.86
MESA LABORATORIES INC /CO/ ( MLAB ) EBITDA Margin is 12.95%
Capital Allocation:
MESA LABORATORIES INC /CO/ ( MLAB ) has paid 0.64 dividends per share and bought back -0.023 million shares in the past 12 months
MESA LABORATORIES INC /CO/ ( MLAB ) has reduced its debt by 217.331 million USD in the last 12 months
Capital Structure:
MESA LABORATORIES INC /CO/ ( MLAB ) Interest-bearing Debt ($MM) as of last quarter is 176
MESA LABORATORIES INC /CO/ ( MLAB ) Annual Working Capital Investments ($MM) are 1
MESA LABORATORIES INC /CO/ ( MLAB ) Book Value ($MM) as of last quarter is 387
MESA LABORATORIES INC /CO/ ( MLAB ) Debt/Capital as of last quarter is 45%
Other Balance Sheet Stats:
MESA LABORATORIES INC /CO/ ( MLAB ) has 35 million in cash on hand as of last quarter
MESA LABORATORIES INC /CO/ ( MLAB ) has 39 million of liabilities due within 12 months, and long term debt 170 as of last quarter
MESA LABORATORIES INC /CO/ ( MLAB ) has 5 common shares outstanding as of last quarter
MESA LABORATORIES INC /CO/ ( MLAB ) has 0 million USD of preferred stock value
Academic Scores:
MESA LABORATORIES INC /CO/ ( MLAB ) Altman Z-Score is 1.96 as of last quarter
MESA LABORATORIES INC /CO/ ( MLAB ) Piotroski Score is 6.00 as of last quarter
Corporate Governance:
MESA LABORATORIES INC /CO/ ( MLAB ) largest shareholder is Dimensional Fund Advisors, Inc. owning 127999 shares at 13.35 ($MM) value
John Bradley Schmieder(an insider) Sold 1000 shares of MESA LABORATORIES INC /CO/ ( MLAB ) for the amount of $123740.00 on 2023-09-15
5.90% of MESA LABORATORIES INC /CO/ ( MLAB ) is held by insiders, and 95.97% is held by institutions
MESA LABORATORIES INC /CO/ ( MLAB ) went public on 1995-01-25
Other MESA LABORATORIES INC /CO/ ( MLAB ) financial metrics:
FCF:36.25
Unlevered Free Cash Flow:0.00
EPS:-0.91
Operating Margin:-0.11
Gross Profit Margin:60.39
Div. Payout Ratio%:-480.85
Div. Growth YoY%:0.00
Equity Return%:-1.27
Beta:0.98
Buffet's Owners Earnings:0.00
Price to Owner's Earnings:0.00
About MESA LABORATORIES INC /CO/ ( MLAB ) :
Mesa Laboratories, Inc. develops, manufactures, and sells life sciences tools and quality control products and services in the United States, Europe, the Asia Pacific, and internationally. The company's Sterilization and Disinfection Control segment manufactures and sells biological, cleaning, and chemical indicators that are used to assess the effectiveness of sterilization and disinfection processes in the hospital, dental, medical device, and pharmaceutical industries. This segment also provides testing and laboratory services primarily to the dental industry. Its Biopharmaceutical Development segment develops, manufactures, and sells automated systems for protein analysis (immunoassays) and peptide synthesis solutions. This segment's solutions include protein analysis comprising analysis equipment, CDs, kits, and buffers; and peptide synthesizers that enables to automate chemically synthesized peptides that are used in the creation of peptide therapies, biomaterials, cosmetics, and general research. The company's Calibration Solutions segment designs, manufactures, and markets quality control and calibration products to measure or calibrate temperature, pressure, pH, humidity, and other such parameters used for health and safety purposes in the hospital, medical device manufacturing, pharmaceutical manufacturing, and various laboratory and healthcare environments. This segment's products include continuous monitoring systems, dialysate meters and consumables, data loggers, gas flow calibration and air sampling equipment, and torque testing systems. Its Clinical Genomics segment develops, manufactures, and sells genetic analysis tools that include MassARRAY system and consumables, including chips, panels, and chemical reagent solutions used by clinical labs to perform genomic clinical testing in several therapeutic areas, such as newborn screenings, pharmacogenetics, and oncology. The company was incorporated in 1982 and is headquartered in Lakewood, Colorado.
User Content from Tickernomics. Created by Luminus.
DISCLAIMER

This web site and its creators are not certified financial advisors. All opinions/suggestions expressed on this website should not be treated as specific inducement to make a particular investment or follow a particular strategy, but only as an expression of an opinion.The Company doesn't warrant the information provided on the website for its completeness or accuracy, and it should not be relied upon as such. The Company is not under any obligation to update or correct any information provided on this website.The content of this website is published in the United States of America and persons who access it agree to do so in accordance with applicable U.S. law.Past performance is not indicative of future results. The Company doesn't guarantee any specific outcome or profit. You should be aware of the real risk of loss in following any strategy or investment discussed on this website.Strategies or investments discussed may fluctuate in price or value. Investors may get back less than invested. Investments or strategies mentioned on this website may not be suitable for you. This material does not take into account your particular investment objectives,financial situation or needs and is not intended as recommendations appropriate for you. You must make an independent decision regarding investments or strategies mentioned on this website. Before acting on information on this website, you should consider whether it is suitable for your particular circumstances and strongly consider seeking advice from your own financial or investment adviser.